# FDA Inspection 1085950 - Sterling Knight Pharmaceuticals, LLC - April 11, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/sterling-knight-pharmaceuticals-llc/0ad3ffe1-8623-44ef-80ea-fb47138d1f4d
Source feed: FDA_Inspections

> FDA Inspection 1085950 for Sterling Knight Pharmaceuticals, LLC on April 11, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085950
- Company Name: Sterling Knight Pharmaceuticals, LLC
- Inspection Date: 2019-04-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1085950 - 2019-04-11](https://www.globalkeysolutions.net/records/fda_inspections/sterling-knight-pharmaceuticals-llc/886d47b4-7bdc-43cc-ae06-274a4209e7ca)
- [FDA Inspection 949854 - 2015-11-17](https://www.globalkeysolutions.net/records/fda_inspections/sterling-knight-pharmaceuticals-llc/e43a684a-92c8-49bc-b0f8-4e0082cfe125)

Company: https://www.globalkeysolutions.net/companies/sterling-knight-pharmaceuticals-llc/dadb3e3e-5edd-4df1-a365-2578a60cdd0c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c